LONDON - When the going gets tough, the tough get going. "That title was fixed some weeks ago, but it turns out to be more relevant than I ever imagined," said the keynote speaker David Brennan, CEO of AstraZeneca plc, addressing BioPartnering Europe delegates Monday. (BioWorld Today) Read More
